<p>Immunoblot analysis of ERK1/2 <i>(A)</i> and p38 MAPK <i>(B)</i> protein expression in 16HBE14o- cells treated with inactivated-H5N1. Cells were untreated or treated with PD98059 (50 μM) or SB203580 (10 μM) as appropriate. One hour later, cells were treated for 30 min with vehicle, allantoic fluid or inactivated-H5N1 before being harvested for immunoblot analysis for the presence of ERK1/2, phospho-ERK1/2 (P-ERK1/2), p38 MAPK or phospho-p38 MAPK (P-p38). Upper panel, representative gels for immunoblot analysis of ERK1/2 and phosphorylated ERK1/2 (P-ERK1/2) <i>(A)</i> or p38 MAPK and phosphorylated p38 MAPK (P-p38) <i>(B)</i>. Lower panel, quantitative analysis of the amount of P-ERK1/2 (<i>A</i>) or P-p38 MAPK <i>(B)</i>, expressed as fo...
<p>The cells were preincubated with U0126 (10 μM) for 18h, then treated with TRPM7 siRNA for 48h, an...
<p>(A) The phosphorylation profile of p53 protein following MNNG treatment. TW01 and NA cells were t...
<p>Cells were transfected with 3 MOI lentiviral based shRNA targeting ERK, JNK, p38, and p65 mRNA fo...
<div><p>(A) Representative immunoblot showing ERK-p, P38-p, and JNK-p, in uninfected cells before (0...
<p>(A) SH-SY5Y cells were treated with 0.01 to 100 µM H<sub>2</sub>O<sub>2</sub> for 5 min. Followin...
<p>Panel <b>A</b> shows inhibition of light chain (LC)-stimulated phosphorylation of ERK ½, and pane...
<p>(<b>A</b>, <b>B</b>) qPCR measurement of levels of mRNA encoding 11β-HSD1 in A549 cells without i...
<p>(A) Cells were treated with different concentrations of LPS for 24 h. Secretion of TNF-α in cultu...
<p>Western blot analysis of p38/MAPK phosphorylation in MCF-7 cells treated with vehicle (0), E2 (pa...
<p>Phosphorylation levels of JNK, ERK, and p38 MAPk following treatment with the inhibitor U0126 (10...
<p>(<b>A</b>) Western blot showing the protein levels of HIF-1α, p53, phosphorylated ERK 1/2 (P-MAPK...
<p>A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 μ...
<p>The cells were transfected with a negative control shRNA (ctrl-shRNA) or a shRNA targeting p38α (...
<p>After the cells were treated with 100 ng/mL of HMGB1 for different time periods, protein was extr...
<p>Cells were incubated 48β-HB (0, 0.6, 1.2, 2.4 or 4.8 mM) in serum-free medium. Phosphorylated-p38...
<p>The cells were preincubated with U0126 (10 μM) for 18h, then treated with TRPM7 siRNA for 48h, an...
<p>(A) The phosphorylation profile of p53 protein following MNNG treatment. TW01 and NA cells were t...
<p>Cells were transfected with 3 MOI lentiviral based shRNA targeting ERK, JNK, p38, and p65 mRNA fo...
<div><p>(A) Representative immunoblot showing ERK-p, P38-p, and JNK-p, in uninfected cells before (0...
<p>(A) SH-SY5Y cells were treated with 0.01 to 100 µM H<sub>2</sub>O<sub>2</sub> for 5 min. Followin...
<p>Panel <b>A</b> shows inhibition of light chain (LC)-stimulated phosphorylation of ERK ½, and pane...
<p>(<b>A</b>, <b>B</b>) qPCR measurement of levels of mRNA encoding 11β-HSD1 in A549 cells without i...
<p>(A) Cells were treated with different concentrations of LPS for 24 h. Secretion of TNF-α in cultu...
<p>Western blot analysis of p38/MAPK phosphorylation in MCF-7 cells treated with vehicle (0), E2 (pa...
<p>Phosphorylation levels of JNK, ERK, and p38 MAPk following treatment with the inhibitor U0126 (10...
<p>(<b>A</b>) Western blot showing the protein levels of HIF-1α, p53, phosphorylated ERK 1/2 (P-MAPK...
<p>A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 μ...
<p>The cells were transfected with a negative control shRNA (ctrl-shRNA) or a shRNA targeting p38α (...
<p>After the cells were treated with 100 ng/mL of HMGB1 for different time periods, protein was extr...
<p>Cells were incubated 48β-HB (0, 0.6, 1.2, 2.4 or 4.8 mM) in serum-free medium. Phosphorylated-p38...
<p>The cells were preincubated with U0126 (10 μM) for 18h, then treated with TRPM7 siRNA for 48h, an...
<p>(A) The phosphorylation profile of p53 protein following MNNG treatment. TW01 and NA cells were t...
<p>Cells were transfected with 3 MOI lentiviral based shRNA targeting ERK, JNK, p38, and p65 mRNA fo...